Joseph DeSimone, a chemist and one of the top researchers at UNC-Chapel Hill, has accepted an appointment as an adjunct member at New York’s Memorial Sloan-Kettering Cancer Center’s Cancer Nanocenter.
As Sarah Avery reports, the appointment is part of an effort to broaden the geographic base of DeSimone's work in North Carolina, and build Sloan-Kettering’s capabilities in nanomedicine.
DeSimone, named by The News & Observer in 2008 as the Tar Heel of the Year, has spent a career at UNC-Chapel Hill in cutting edge research. In his early work, he developed a process that eliminated toxins from the dry cleaning industry. More recently, his lab created tiny particles that can be tailor-made in different shapes for use in medicine and other applications.
That technology is now the focus of a company DeSimone founded, Liquidia Technologies.
“One of the limitations in the field of nanomedicine is the shortage of scientists trained in the key technologies of this field. Joe’s collaboration in cancer therapeutics at UNC has had a major impact on our program and will undoubtedly enhance work being done at Memorial Sloan Kettering,” said Shelton Earp, Director of UNC Lineberger Comprehensive Cancer Center, where DeSimone is a member.